Navigation Links
Par Pharmaceutical to Host Analyst Day on January 6, 2012
Date:12/5/2011

WOODCLIFF LAKE, N.J., Dec. 5, 2011 /PRNewswire/ -- Par Pharmaceutical Companies, Inc. (NYSE: PRX) will hold an Analyst Day from 9:00am to 12:00pm EST on Friday, January 6, 2012 at the Millennium Hotel, 145 West 44th Street, New York City. Chairman and Chief Executive Officer, Patrick G. LePore, and other members of the senior management team will present an overview of the company's growth strategy, current products and pipelines, and business outlook to analysts and investors. This event will be webcast live on Par's website at www.parpharm.com or http://phx.corporate-ir.net/phoenix.zhtml?p=irol-eventDetails&c=81806&eventID=4251089 beginning at 9:00am. An archive of the webcast will be available within three hours of the conclusion of the event and can be viewed at the same link.

About Par Pharmaceutical Companies, Inc.
Par Pharmaceutical Companies, Inc. is a U.S.-based specialty pharmaceutical company. Through its wholly owned subsidiary's two operating divisions, Par Pharmaceutical and Strativa Pharmaceuticals, it develops, manufactures and markets higher-barrier-to-entry generic drugs and niche, innovative proprietary pharmaceuticals. For press releases and other company information, visit http://www.parpharm.com


'/>"/>
SOURCE Par Pharmaceutical Companies, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Radient Pharmaceuticals Two Abstracts Submitted to 2012 Gastrointestinal Cancers Symposium (ASCO) Regarding Onko-Sure® Utility in Colorectal Cancer Are Accepted for Presentation
2. Amherst-Based Pharmaceutical Company Files Federal Lawsuit Accusing Competitor of False Claims Regarding the Efficacy of Infasurf®, its Life-Saving Respiratory Drug for Premature Infants
3. Successful Market Education Strategies and Tactics for New Pharmaceutical Product Launches in the Oncology Therapeutic Area
4. Organizational Design and Structure Benchmarks for Pharmaceutical Commercial Functions Accessed Quickly Through Best Practices, LLCs New Database Search Function
5. Lyophilisation for Pharmaceuticals: Technology and Services Market 2011-2021
6. Arbor Pharmaceuticals Announces Filing of First NDA
7. Hybrid Fuels, Inc. Acquires Marketing Company Focused on Multi-Billion Dollar Nutraceutical/Pharmaceutical Industry
8. Multiple Data Presentations on Syndax Pharmaceuticals Entinostat at Upcoming Scientific Conferences
9. Auxilium Pharmaceuticals, Inc. Announces First Patient Dosed in XIAFLEX® Study for Frozen Shoulder Syndrome
10. Radient Pharmaceuticals Corporation Receives $500,000 in New Capital
11. Merrimack Pharmaceuticals Initiates Enrollment in a Phase 1 Combination Study of MM-121 and Multiple Anticancer Therapies in Patients with Advanced Solid Tumors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2016)... , Nov. 29, 2016 Several leading Alzheimer,s ... Accera, Inc. at 11 a.m. EST on ... Conference on Clinical Trials for Alzheimer,s Disease (CTAD). The ... in Alzheimer,s disease and therapeutic targets that address deficient ... "Following the recent failure of another therapy targeting the ...
(Date:12/5/2016)... BOCA RATON, Fla. , Dec. 5, ... Commercialization of Public Research (the Florida Institute) ... agreement SegAna, LLC, an Orlando ... Central Florida. The Florida Institute supports new company ... funding gaps for companies spinning out of Florida-based universities ...
(Date:12/5/2016)... According to a new market research report "Cartilage Repair/ Cartilage ... Scaffolds, Cell-free composites), Application (Hyaline Cartilage, Fibrocartilage), by Region - Forecast ... USD 779.8 Million by 2021 from USD 414.6 Million in 2016, ... 2016 to 2021. Continue Reading ... ...
Breaking Medicine Technology:
(Date:12/6/2016)... ... December 06, 2016 , ... The Behavioral Health ... Distinction, recognizing the organization as a top behavioral service provider in the country. ... clinical quality, staff satisfaction and qualifications, and consumer satisfaction. These areas are measured ...
(Date:12/6/2016)... ... December 06, 2016 , ... Experimentation ... research and development, largely due to its potential for revolutionizing human disease treatment. ... and human induced pluripotent stem cells (hiPSCs). , Both platforms have distinct ...
(Date:12/6/2016)... ... December 06, 2016 , ... METTLER TOLEDO has ... knowledge resources, including white papers, guides, handbooks, case studies, magazines, webinars, videos, catalogs, ... more than 9,000 documents, webinars and videos available online, visit the METTLER ...
(Date:12/6/2016)... ... ... 'Tis the season for family, festivity, food and fun! Temptation abounds, and ... eating healthy, staying active, and taking medication and doing daily foot health checks (a ... "Shopping trips, parties and family gatherings can take their toll on our feet during ...
(Date:12/6/2016)... (PRWEB) , ... December 06, 2016 , ... ... the availability of the newly updated International Audit Protocol Consortium (IAPC) EHS audit ... EHS audit protocols to understand the scope of their EHS regulatory obligations and ...
Breaking Medicine News(10 mins):